Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure

Current therapeutic strategies for acute heart failure (AHF) are based on traditional inotropic agents that are often associated with untoward effects; therefore, finding new effective approaches with a safer profile is dramatically needed. Istaroxime is a novel compound, chemically unrelated to car...

Descripción completa

Detalles Bibliográficos
Autores principales: Forzano, Imma, Mone, Pasquale, Mottola, Gaetano, Kansakar, Urna, Salemme, Luigi, De Luca, Antonio, Tesorio, Tullio, Varzideh, Fahimeh, Santulli, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786901/
https://www.ncbi.nlm.nih.gov/pubmed/36556120
http://dx.doi.org/10.3390/jcm11247503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786901/
https://www.ncbi.nlm.nih.gov/pubmed/36556120
http://dx.doi.org/10.3390/jcm11247503

Ejemplares similares